Showing results (171-180 of 183) with videos related to

Sort By:
Pageof 19
The New England Journal of Medicine|October 6, 2021
Myocarditis after BNT162b2 mRNA Vaccine against Covid-19 in IsraelDror Mevorach, Emilia Anis, Noa Cedar, et al.
ESC Heart Failure|September 19, 2025
SGLT2 inhibitors for the prevention and treatment of heart failure: A scientific statement of the HFA and the HFAIMarco Metra, Daniela Tomasoni, Marianna Adamo, et al.
European Journal of Heart Failure|May 30, 2025
Insights into the European heart failure epidemiologyPetar M Seferović, Marija Polovina, Gianluigi Savarese, et al.
European Journal of Heart Failure|June 22, 2016
European Society of Cardiology Heart Failure Long-Term Registry (ESC-HF-LT): 1-year follow-up outcomes and differences across regionsMaria G Crespo-Leiro, Stefan D Anker, Aldo P Maggioni, et al.
European Journal of Heart Failure|April 12, 2023
Geographic differences in patients with acute myocardial infarction in the PARADISE-MI trialJawad H Butt, Brian L Claggett, Zi M Miao, et al.
European Journal of Heart Failure|June 22, 2013
Organization of heart failure management in European Society of Cardiology member countries: survey of the Heart Failure Association of the European Society of Cardiology in collaboration with the Heart Failure National Societies/Working GroupsPetar M Seferovic, Stefan Stoerk, Gerasimos Filippatos, et al.
European Journal of Heart Failure|November 10, 2025
Adherence to guideline-directed medical treatments in heart failure. A scientific statement of the Heart Failure Association (HFA) of the ESC and the ESC Working Group on Cardiovascular PharmacotherapyGianluigi Savarese, Felix Lindberg, Antonio Cannata, et al.
The New England Journal of Medicine|April 8, 2024
Empagliflozin after Acute Myocardial InfarctionJaved Butler, W Schuyler Jones, Jacob A Udell, et al.
Circulation|April 6, 2024
Effect of Empagliflozin on Heart Failure Outcomes After Acute Myocardial Infarction: Insights From the EMPACT-MI TrialAdrian F Hernandez, Jacob A Udell, W Schuyler Jones, et al.
Journal of the American College of Cardiology|April 8, 2024
Left Ventricular Function, Congestion, and Effect of Empagliflozin on Heart Failure Risk After Myocardial InfarctionJacob A Udell, Mark C Petrie, W Schuyler Jones, et al.
Pageof 19